Everence Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $762K | Sell |
|
|||||
|
2025
Q2 | $1.59M | Sell |
|
|||||
|
2025
Q1 | $2.22M | Sell |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $3.93M | Hold |
|
|||||
|
2024
Q2 | $3.33K | Hold |
|
|||||
|
2024
Q1 | $3.6K | Hold |
|
|||||
|
2023
Q4 | $3.29M | Buy |
|
|||||
|
2023
Q3 | $3.02K | Hold |
|
|||||
|
2023
Q2 | $2.7M | Hold |
|
|||||
|
2023
Q1 | $3.02K | Hold |
|
|||||
|
2022
Q4 | $2.65K | Hold |
|
|||||
|
2022
Q3 | $2.53M | Buy |
|
|||||
|
2022
Q2 | $1.83M | Hold |
|
|||||
|
2022
Q1 | $2.17M | Hold |
|
|||||
|
2021
Q4 | $1.96M | Buy |
|
|||||
|
2021
Q3 | $1.51M | Hold |
|
|||||
|
2021
Q2 | $1.4M | Hold |
|
|||||
|
2021
Q1 | $1.18M | Hold |
|
|||||
|
2020
Q4 | $1.21M | Buy |
|
|||||
|
2020
Q3 | $1.25M | Buy |
|
|||||
|
2020
Q2 | $1.36M | Hold |
|
|||||
|
2020
Q1 | $1.08M | Hold |
|
|||||
|
2019
Q4 | $834K | Buy |
|
|||||
|
2019
Q3 | $433K | Hold |
|
|||||
|
2019
Q2 | $489K | Hold |
|
|||||
|
2019
Q1 | $641K | Sell |
|
|||||
|
2018
Q4 | $649K | Hold |
|
|||||
|
2018
Q3 | $702K | Hold |
|
|||||
|
2018
Q2 | $599K | Hold |
|
|||||
|
2018
Q1 | $598K | Hold |
|
|||||
|
2017
Q4 | $653K | Hold |
|
|||||
|
2017
Q3 | $777K | Buy |
|
|||||
|
2017
Q2 | $603K | Hold |
|
|||||
|
2017
Q1 | $475K | Hold |
|
|||||
|
2016
Q4 | $450K | Sell |
|
|||||
|
2016
Q3 | $708K | Hold |
|
|||||
|
2016
Q2 | $615K | Hold |
|
|||||
|
2016
Q1 | $635K | Hold |
|
|||||
|
2015
Q4 | $957K | Buy |
|
|||||
|
2015
Q3 | $670K | Hold |
|
|||||
|
2015
Q2 | $735K | Hold |
|
|||||
|
2015
Q1 | $596K | Hold |
|
|||||
|
2014
Q4 | $591K | Buy |
|